跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHARMA-SIMVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PHARMA-SIMVASTATIN
Authorized
STANDARD
PHARMA-SIMVASTATIN
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b766401c47f4ad30
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
b766401c47f4ad30
Drug Approval Canada Name
PHARMA-SIMVASTATIN
Product Name
PHARMA-SIMVASTATIN
Status
Marketed
Status Date
2017-11-29
Original Market Date
2017-11-29
Din
02469979
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA01 SIMVASTATIN
Atc Name
c 10 aa 01
Aig Number
0122415001
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
SIMVASTATIN
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b766401c47f4ad30
Type
Standard
Back to Health Canada Approvals